Caxton Associates LP purchased a new position in Plexus Corp. (NASDAQ:PLXS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 2,882 shares of the technology company's stock, valued at approximately $451,000.
A number of other large investors have also modified their holdings of the company. BNP Paribas Financial Markets increased its stake in Plexus by 14.7% during the 4th quarter. BNP Paribas Financial Markets now owns 11,335 shares of the technology company's stock valued at $1,774,000 after buying an additional 1,455 shares during the period. Algert Global LLC raised its stake in Plexus by 121.3% during the 4th quarter. Algert Global LLC now owns 101,336 shares of the technology company's stock valued at $15,857,000 after purchasing an additional 55,546 shares during the last quarter. AXA S.A. grew its stake in shares of Plexus by 4.1% in the 4th quarter. AXA S.A. now owns 36,794 shares of the technology company's stock valued at $5,758,000 after purchasing an additional 1,451 shares during the period. Schonfeld Strategic Advisors LLC bought a new stake in shares of Plexus in the 4th quarter valued at approximately $321,000. Finally, Northern Trust Corp grew its stake in shares of Plexus by 10.0% in the 4th quarter. Northern Trust Corp now owns 332,100 shares of the technology company's stock valued at $51,967,000 after purchasing an additional 30,163 shares during the period. Institutional investors and hedge funds own 94.45% of the company's stock.
Insiders Place Their Bets
In related news, CEO Todd P. Kelsey sold 2,000 shares of Plexus stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $140.00, for a total value of $280,000.00. Following the transaction, the chief executive officer now directly owns 87,665 shares of the company's stock, valued at $12,273,100. This trade represents a 2.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Randy J. Martinez sold 887 shares of Plexus stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $140.52, for a total transaction of $124,641.24. Following the completion of the transaction, the director now directly owns 4,831 shares in the company, valued at $678,852.12. This trade represents a 15.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,137 shares of company stock worth $577,916 over the last three months. Insiders own 1.76% of the company's stock.
Plexus Stock Up 1.2%
Shares of PLXS stock traded up $1.61 during trading on Tuesday, reaching $132.97. The company's stock had a trading volume of 51,140 shares, compared to its average volume of 166,743. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. The business has a fifty day moving average price of $124.11 and a 200-day moving average price of $143.34. Plexus Corp. has a one year low of $100.96 and a one year high of $172.89. The company has a market cap of $3.60 billion, a price-to-earnings ratio of 30.85 and a beta of 0.80.
Plexus (NASDAQ:PLXS - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The technology company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.12. Plexus had a net margin of 3.03% and a return on equity of 10.36%. The firm had revenue of $980.17 million for the quarter, compared to analyst estimates of $980.07 million. During the same period in the prior year, the firm posted $0.94 earnings per share. The company's quarterly revenue was up 1.4% compared to the same quarter last year. Analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current year.
Wall Street Analysts Forecast Growth
PLXS has been the subject of a number of recent analyst reports. Needham & Company LLC reiterated a "buy" rating and set a $162.00 target price (down previously from $172.00) on shares of Plexus in a research report on Friday, April 25th. Benchmark dropped their target price on shares of Plexus from $170.00 to $160.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Finally, Stifel Nicolaus set a $145.00 target price on shares of Plexus in a research report on Thursday, April 24th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Plexus presently has a consensus rating of "Moderate Buy" and an average target price of $155.67.
Read Our Latest Stock Report on PLXS
Plexus Company Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Further Reading
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
